Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
FEMOSTON Tabl 2/10 mg 28 Stk
Drug
Femoston, comprimés
Hormonsubstitution nach der Menopause
07.08.6. – combinations
HAM – Human medicine
TAB – Tablet
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/17/1996
12/31/9999
Dosage strength
Femoston 2/10 mg, comprimés
Substitution hormonale après la ménopause
04
Z – approved
Package
7680531280336
No information made available
A/R – Authorised / referenced
28 tablet(s)
033
Z – approved
Declaration
Component I)
2 mg estradiolum
2.06 mg estradiolum hemihydricum
2.06 mg estradiolum hemihydricum
118.2 mg lactosum monohydricum
hypromellosum
maydis amylum
silica colloidalis anhydrica
magnesii stearas
hypromellosum
talcum
macrogolum 400
E 171
E 172 (rubrum)
E 172 (flavum)
E 172 (nigrum)
hypromellosum
maydis amylum
silica colloidalis anhydrica
magnesii stearas
hypromellosum
talcum
macrogolum 400
E 171
E 172 (rubrum)
E 172 (flavum)
E 172 (nigrum)
Component II)
2 mg estradiolum
2.06 mg estradiolum hemihydricum
10 mg dydrogesteronum
2.06 mg estradiolum hemihydricum
10 mg dydrogesteronum
109.4 mg lactosum monohydricum
hypromellosum
maydis amylum
silica colloidalis anhydrica
magnesii stearas
hypromellosum
talcum
macrogolum 400
E 171
E 172 (flavum)
hypromellosum
maydis amylum
silica colloidalis anhydrica
magnesii stearas
hypromellosum
talcum
macrogolum 400
E 171
E 172 (flavum)
Spezialitätenliste***
SL
-
-
15.90
None
No
10%
No
Authorisation holder
7601001000995
Labatec Pharma SA
rue du Cardinal-Journet 31
1217 Meyrin (GE)
rue du Cardinal-Journet 31
1217 Meyrin (GE)
Date of revision of the text
4/3/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.